Ticker
GOSSCompany Name
GOSSAMER BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Liabilities | Working Capital |
---|---|---|---|
6/30/2025 | $ 235.9M | $ 53.59M | $ 182.3M |
3/31/2025 | $ 275.48M | $ 48.22M | $ 227.25M |
12/31/2024 | $ 309.89M | $ 45.01M | $ 264.88M |
9/30/2024 | $ 344.27M | $ 51.09M | $ 293.18M |
6/30/2024 | $ 370.9M | $ 45.19M | $ 325.72M |
3/31/2024 | $ 255.27M | $ 35.82M | $ 219.45M |
12/31/2023 | $ 306.52M | $ 51.6M | $ 254.92M |
9/30/2023 | $ 341.49M | $ 42.32M | $ 299.17M |
6/30/2023 | $ 173.38M | $ 40.14M | $ 133.24M |
3/31/2023 | $ 210.41M | $ 40.57M | $ 169.84M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for GOSSAMER BIO INC is calculated as follows: AssetsC [ $ 566.21M ] - LiabilitesC [ $ 32.61M ]
(=) Working Capital [ $ 533.6M ]
Minimum
Jun 30, 2023
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 2.79K |
---|---|
min | $ -457.39M |
max | $ 607.04M |
average | $ 96.42M |
median | $ 32.11M |
std | $ 173.65M |